NCAPG has been shown to be relevant in a number of different cancer types, including liver cancer (26), bladder cancer (27), renal cell carcinoma (28), multiple myeloma (29), melanoma (30) and breast cancer (31). The gene discussed is NCAPG; the disease is plasma cell myeloma.